STOCK TITAN

Cryoport to Report Second Quarter 2026 Financial Results on August 6, 2026

(Neutral)
(Neutral)
Tags
earnings date

Cryoport (Nasdaq: CYRX) will report its financial results for the second quarter ended June 30, 2026 on Thursday, August 6, 2026, after U.S. markets close. A detailed document, “Cryoport Second Quarter 2026 in Review,” covering financial, operational performance and a general business update, will be released at 4:05 p.m. ET the same day on the company’s investor relations site.

Cryoport management will host a Q&A-format conference call on August 6, 2026 at 5:00 p.m. ET, accompanied by a slide deck and a live webcast accessible via the Investor Relations section of www.cryoportinc.com. U.S. participants can dial 1-800-717-1738, while international participants can dial 1-646-307-1865, requesting the “Cryoport Call” or Conference ID 1142151. A webcast replay will be available on the company’s website, and a dial-in replay will be offered until August 13, 2026 at 1-844-512-2921 (U.S.) or 1-412-317-6671 (International) using replay code 1142151#.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – CYRX

-2.38%
3 alerts
-2.38% Session close to close
-2.0% Trough Tracked
$827.61M Market Cap
0.8x Rel. Volume

In the Jul 23 session, CYRX declined 2.38%, reflecting a moderate negative market reaction. Argus tracked a trough of -2.0% from its starting point during tracking. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NASHVILLE, Tenn., July 23, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, today announced that the Company will report financial results for the second quarter ended June 30, 2026 on Thursday, August 6, 2026 after U.S. markets close.

Cryoport logo 2024

In addition to the earnings release, a document titled "Cryoport Second Quarter 2026 in Review", providing a review of Cryoport's financial and operational performance and a general business update, will be issued at 4:05 p.m. ET on Thursday, August 6, 2026. The document is designed to be read in advance of the questions and answers conference call and will be accessible at https://ir.cryoportinc.com/news-events/ir-calendar.

Cryoport management will host a conference call the same day at 5:00 p.m. ET. The conference call will be in the format of a questions and answers session and will address questions members of the investment community have regarding the Company's reported results. A slide deck will accompany the call.

Conference Call Information

Date:

Thursday, August 6, 2026

Time:

5:00 p.m. ET

Dial-in numbers:

1-800-717-1738 (U.S.), 1-646-307-1865 (International)

Confirmation code:

Request the "Cryoport Call" or Conference ID: 1142151

Live webcast:

'Investor Relations' section at www.cryoportinc.com or click here.

Please allow 10 minutes prior to the call to visit this site to download and install any necessary audio software.

The questions and answers call will be recorded and available approximately three hours after completion of the live event in the Investor Relations section of the Company's website at www.cryoportinc.com for a limited time. To access the replay of the questions and answers click here. A dial-in replay of the call will also be available to those interested, until August 13, 2026. To access the replay, dial 1-844-512-2921 (United States) or 1-412-317-6671 (International) and enter replay entry code: 1142151#.

About Cryoport, Inc
Cryoport, Inc. (Nasdaq: CYRX), is a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, with an emphasis on regenerative medicine. We support biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products designed to minimize risk and maximize reliability across the temperature-controlled supply chain for the life sciences. Our integrated supply chain platform includes the Cryoportal® Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized BioLogistics, biostorage, BioServices, cryopreservation services, and cryogenic systems, which in varying combinations deliver end-to-end solutions that meet the rigorous demands of the life sciences. With innovation, regulatory compliance, and agility at our core, we are "Enabling the Future of Medicine™."

Headquartered in Nashville, Tennessee, our company maintains a strong global presence with operations across the Americas, EMEA, and APAC.

For more information, visit www.cryoportinc.com or follow via LinkedIn at https://www.linkedin.com/company/cryoportinc or @cryoport on X at www.x.com/cryoport for live updates.

Forward-Looking Statements
Statements in this press release which are not purely historical, including statements regarding Cryoport's intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that Cryoport's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic and geopolitical conditions, supply chain constraints, inflationary pressures, the effects of foreign currency fluctuations, trends in the products markets, variations in Cryoport's cash flow, market acceptance risks, and technical development risks. Cryoport's business could be affected by other factors discussed in Cryoport's SEC reports, including in the "Risk Factors" section of its most recently filed periodic reports on Form 10-K and Form 10-Q, as well as in its subsequent filings with the SEC. The forward-looking statements contained in this press release speak only as of the date hereof and Cryoport cautions investors not to place undue reliance on these forward-looking statements. Except as required by law, Cryoport disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cryoport-to-report-second-quarter-2026-financial-results-on-august-6-2026-302832639.html

SOURCE Cryoport, Inc.

FAQ

When will Cryoport (NASDAQ: CYRX) release its Q2 2026 financial results?

Cryoport will release its Q2 2026 financial results on Thursday, August 6, 2026, after U.S. markets close. According to Cryoport, a detailed review document will be posted at 4:05 p.m. ET the same day on its investor relations website.

What time is Cryoport's Q2 2026 earnings conference call for CYRX investors?

Cryoport’s Q2 2026 earnings Q&A conference call is scheduled for 5:00 p.m. ET on August 6, 2026. According to Cryoport, the call will follow the results release and a review document, and will focus on answering investor questions on reported results.

How can investors access the Cryoport (CYRX) Q2 2026 earnings call by phone?

Investors can join the Cryoport Q2 2026 call by dialing 1-800-717-1738 in the U.S. or 1-646-307-1865 internationally. According to Cryoport, participants should request the “Cryoport Call” or provide Conference ID 1142151 to access the session.

Is there a webcast for Cryoport's Q2 2026 CYRX earnings Q&A session?

Yes, Cryoport will provide a live webcast of its Q2 2026 Q&A session via the Investor Relations section at www.cryoportinc.com. According to Cryoport, investors should allow about 10 minutes beforehand to install any required audio software for the webcast.

How can investors access the replay of Cryoport's Q2 2026 earnings call?

A replay of Cryoport’s Q2 2026 Q&A call will be available on its Investor Relations website for a limited time. According to Cryoport, a dial-in replay is also available until August 13, 2026 using 1142151# at the listed U.S. and international numbers.

What is included in Cryoport's 'Second Quarter 2026 in Review' document for CYRX?

The “Cryoport Second Quarter 2026 in Review” document will summarize financial and operational performance plus a general business update. According to Cryoport, it is designed to be read before the Q&A call and will be posted at 4:05 p.m. ET on August 6, 2026.